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Intensiﬁed vmPFC surveillance over PTSS under perturbed
microRNA-608/AChE interaction
T Lin1,2,9, A Simchovitz3,9, S Shenhar-Tsarfaty3,9, S Vaisvaser1, R Admon1, G Hanin3, M Hanan3, E Kliper1, Y Bar-Haim2,4, N Shomron5,
G Fernandez6, G Lubin7, E Fruchter7, T Hendler1,2,4,8,10 and H Soreq3,10
Trauma causes variable risk of posttraumatic stress symptoms (PTSS) owing to yet-unknown genome–neuronal interactions. Here,
we report co-intensiﬁed amygdala and ventromedial prefrontal cortex (vmPFC) emotional responses that may overcome PTSS in
individuals with the single-nucleotide polymorphism (SNP) rs17228616 in the acetylcholinesterase (AChE) gene. We have recently
shown that in individuals with the minor rs17228616 allele, this SNP interrupts AChE suppression by microRNA (miRNA)-608, leading
to cortical elevation of brain AChE and reduced cortisol and the miRNA-608 target GABAergic modulator CDC42, all stress-
associated. To examine whether this SNP has effects on PTSS and threat-related brain circuits, we exposed 76 healthy Israel Defense
Forces soldiers who experienced chronic military stress to a functional magnetic resonance imaging task of emotional and neutral
visual stimuli. Minor allele individuals predictably reacted to emotional stimuli by hyperactivated amygdala, a hallmark of PTSS and
a predisposing factor of posttraumatic stress disorder (PTSD). Despite this, minor allele individuals showed no difference in PTSS
levels. Mediation analyses indicated that the potentiated amygdala reactivity in minor allele soldiers promoted enhanced vmPFC
recruitment that was associated with their limited PTSS. Furthermore, we found interrelated expression levels of several miRNA-608
targets including CD44, CDC42 and interleukin 6 in human amygdala samples (N= 7). Our ﬁndings suggest that miRNA-608/AChE
interaction is involved in the threat circuitry and PTSS and support a model where greater vmPFC regulatory activity compensates
for amygdala hyperactivation in minor allele individuals to neutralize their PTSS susceptibility.
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INTRODUCTION
Posttraumatic stress disorder (PTSD) is a severely debilitating
psychiatric condition, especially in combat soldiers at high risk for
trauma or chronic stress exposure.1,2 PTSD, however, develops
only in a subset of those experiencing such events,3 pointing to
individual differences in vulnerability and resiliency. The variable
responses to stressful situations manifest in healthy stress-
exposed individuals as subthreshold posttraumatic stress symp-
toms (PTSS), known to increase the risk for PTSD4 and cause
impairments in daily life situation,5,6 including difﬁculties in
emotion regulation.7 Although several neural and genetic risk
factors for PTSS are known,8–11 the molecular mechanisms
underlying the variable intensity of such symptoms remain
elusive.
Most imaging genetic studies in PTSS and PTSD focused on
polymorphisms in coding regions of candidate genes.9,12,13
However, the great majority of genetic polymorphisms are located
in noncoding regulatory regions.14 One of these is the single-
nucleotide polymorphism (SNP rs17228616) C2098A substitution
in the ‘seed’ domain of miRNA-608 binding site, at the 3′-
untranslated region of the acetylcholinesterase (AChE) gene. We
have recently shown that individuals with the minor A-allele
demonstrate weakened interaction between miRNA-608 and the
AChE gene.15 These individuals also exhibit reduced cortisol and
their cortical tissues present excessive brain AChE hydrolytic
activity, accompanied by decreases in other predicted neuronal
protein targets of miRNA-608, including the Rho GTPase CDC42
involved in GABAergic signaling and the inﬂammation-regulating
cytokine interleukin 6 (IL-6). These effects were attributed to
weakened AChE interaction with the primate-speciﬁc regulatory
miRNA-608,15,16 and are all stress-associated and predicting PTSS
and PTSD.15,17,18 Intriguingly, a recent genome-wide association
study has reported signiﬁcant association between the
rs78011900 SNP, which is in full-linkage disequilibrium with
rs17228616, and hypertension19 that is also related to PTSD.20 As
the predicted cholinergic/GABAergic and inﬂammatory imbalance
may modify the inherited risk or resiliency to develop stress-
related symptoms following stressful challenges, we initiated a
study of the functional consequences of this genetic variation on
the development of PTSS symptoms that indicate a risk of PTSD
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and the relation of the rs78011900 SNP to the threat neural
circuitry.
The amygdala, hippocampus and prefrontal cortex have
interrelated roles in PTSS and PTSD pathophysiology8,21,22 and
receive high levels of cholinergic and miRNA inputs.23,24 Rodent
studies show that pharmacological and molecularly induced
suppression of hippocampal AChE activity associate with
increased anxiety- and depression-like behaviors and decreased
resilience to repeated stress.25 This plausibly involves stress-
impaired hippocampal inhibitory feedback to the amygdala,26
which may lead to enhanced amygdala reactivity, a hallmark and a
predisposing factor of PTSD.8,24,27–29 Excessive acetylcholine (ACh)
release in the amygdala strengthens the associations between
environmental stimuli and stressful events, potentially contribut-
ing to maladaptive learning and underlying affective disorders.30
Human studies indeed demonstrate that increases in ACh
signaling contribute to stress-related illnesses, such as major
depression.31 As the rs17228616 polymorphism is related to
excessive brain AChE hydrolytic activity,15 we surmised that the
AChE gene is close to its maximal expression capacity in
individuals with the minor allele. This would limit their ability to
react to a changing environment by overproducing AChE to
suppress the induced stress. We expected that this would be
manifested by enhanced neural response of the threat circuit,
including the amygdala which is rich in both GABAergic synapses
and AChE.32 In addition, animal studies have demonstrated
involvement of inherited tendencies of AChE increases in
response to stress,33 miRNA suppression of brain AChE (by
miRNA-132) which limits stress-induced cognitive impairments,34
and CDC42 suppression leading to anxiogenic reaction.15 There-
fore, we predicted modulated PTSS reactions in individuals with
the minor allele of the rs17228616 SNP.
How individuals compensate for risk-associated genotypes is a
challenging, scarcely studied issue. A neural candidate for coping
with exaggerated amygdala activity is the ventromedial prefrontal
cortex (vmPFC). This region is activated when a negative
emotional response is suppressed, in a manner related to the
elimination of previously learned associations of threat-
conditioned signals.35,36 Under normal conditions, suppressing
messages by the vmPFC lead to amygdala downregulation in
response to negative stimuli, whereas PTSD patients show less
activity in the vmPFC than healthy volunteers when experiencing
or regulating emotions.37 This indicates vmPFC involvement in the
process of regulation and thus resilience to trauma. In the current
study, we used functional magnetic resonance imaging (fMRI) to
examine how the rs17228616 polymorphism in the AChE gene
impacts PTSS following chronic military stress exposure; speciﬁ-
cally, we asked whether it serves as a vulnerability, resilience or an
inert factor, and what are its functional inﬂuences on the human
amygdala and vmPFC responses to stressful challenges.
MATERIALS AND METHODS
fMRI experiment
Participants. The participants were 76 Israel Defense Forces soldiers (13
females; age 18–19 years) who experienced 1 year of chronic military stress
during their mandatory service. Of those, 29 participants (Group A) served
as combat paramedics and 47 (Group B) were recruited after 1 year of
intensive and advanced combat training. During military training, the
participants were exposed to a wide variety of stressful physical and
psychological demands, including sleep restrictions, prolonged periods of
physical survival challenges, face-to-face combat training and counter-
terrorism combat course, that have been shown to affect well-being38 and
may impact the development of stress-related symptoms.1,2 The fMRI data
of Group A was already published by our group.29 As there were no
differences in amygdala and vmPFC activity or in PTSS between
paramedics and soldiers in training (all Fo1.28, P40.25), all 76 volunteers
were considered as a single group. All participants had no reported history
of psychiatric or neurological disorders, no current use of psychoactive
drugs, no family history of major psychiatric disorders and no incidence of
childhood abuse or potentially traumatic events before military
enrollment.
Genotyping. DNA was extracted from saliva samples collected with an
OrageneTM DNA Self-Collection Kit in Group A and from blood samples in
group B, using commercial kits. Genotyping of the A-allele of rs17228616
(C2098A) versus the C-allele (Figure 1a) was performed using TaqMan
genotyping primers and AccuStart genotyping ToughMix low ROX (Quanta
BioSciences, Gaithersburg, MD, USA). To further differentiate between
homozygous (AA) and heterozygous (CA) rs17228616 individuals, PCR-
ampliﬁed DNA was fully sequenced. The participants were categorized
Figure 1. rs17228616 single-nucleotide polymorphism impairs hsa-
miR-608/AChE interaction. (a) Schematic illustration of the AChE
transcript, exon numbers and the rs17228616 location, with the C to
A (C2098A) major to minor allele substitution interrupting hsa-
miR-608 binding. (b) Increased activation within the amygdala
region of interest (ROI; − 28, 0, − 21) for the minor allele (AA, AC,
n= 13) relative to the major allele (CC, n= 63) group. (c) Limited
elevation in posttraumatic stress symptoms (PTSS, z-score) in the
minor allele (AA, AC, n= 13) relative to major allele (CC, n= 58)
group. (d) Increased activation within the ventromedial prefrontal
cortex (vmPFC) ROI (0, 50, − 12) for the minor allele (AA, AC, n= 13)
relative to the major allele (CC, n = 63) group. The data are
represented as mean± s.e. Bar charts in a and c show the mean of
beta values across all voxels in the ROIs for emotional versus neutral
stimuli. *Po0.05. AChE, acetylcholinesterase.
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according to DNA sequencing: carriers of one or two copies of the minor
A-allele of rs17228616C (AA/CA) were assigned to the minor allele group
(N= 13), whereas C homozygotes (CC) were assigned to the major allele
group (N= 63).
fMRI visual task. The participants viewed backward-masked colored
photographed pictures of three contents (military, medical and neutral)
presented for either 33 or 83 ms in a block design and were asked to
indicate whether they recognized a person or an object as described in ref.
29 (see Supplementary Materials and Methods for details).
Assessment of PTSS. The PTSS levels in Group A were evaluated using the
posttraumatic stress diagnostic scale questionnaire (PDS).39 In Group B, the
symptoms were evaluated with the military version of the 17-item PTSD
checklist,40 which speciﬁcally asks about symptoms related to stressful
military experiences. As each of these questionnaires uses different scales,
we calculated z-scores for each group, enabling to integrate data from
both groups. Five participants did not complete the PTSS questionnaires,
and thus were excluded from analyses concerning this variable.
Mediation analysis. The mediation indirect effects were tested using the
PROCESS macro in SPSS,41 which tests indirect effects using a bootstrap
approach. The indirect effect was considered to be signiﬁcant if its 95%
bootstrap conﬁdence intervals from 10 000 iterations did not include zero
at P=0.05. In all indirect effect analyses, A-allele carriers were coded as 1.
Amygdala brain samples
The dissected amygdala tissues from non-demented control volunteers
(n= 7, three males, four females) were provided by the Netherlands Brain
Bank (Supplementary Table S1). Written informed consent from donors or
their next of kin, as well as ethical approval was obtained in all the cases.
The tissues were kept at − 70 degrees until RNA extraction, and were used
for quantitative PCR analysis. RNA extraction from brain tissues, cDNA
synthesis, quantitative PCR measurements and data analysis were
essentially performed as in refs 15,16 (see Supplementary Materials and
Methods for details). DNA was extracted as described in ref. 15 followed by
genotyping of PCR product ampliﬁcation via Illumina sequencing.
Unfortunately, we could not ﬁnd human vmFPC tissues, so we could not
extend these tests to the vmPFC.
RESULTS
The coding regions of the genome account for less than 2% of the
entire human DNA,42 and numerous noncoding genomic domains
contribute to individual differences in reactivity to neural diseases,
including threat and its regulation.43,44 Nevertheless, most
anxiety-related imaging genetic studies focus on those simple-
to-explain polymorphisms in the coding regions of candidate
genes.9 In the present study, we selected the rs17228616 SNP in
the noncoding region of the AChE gene to investigate gene–
environment brain interactions as those are reﬂected in PTSS. This
was achieved by combining genotype and brain transcript tests
with fMRI measurements of amygdala and vmPFC responses to
emotional stimuli in a military population at high risk for chronic
stress exposure, known to impact the development of stress-
related symptoms.1,29
Genotyping results
The rs17228616 SNP in the AChE gene was present in 17% of 76
participants, fourfold higher incidence than in Caucasians but
twofold less than in African American.15 Thirteen participants
(17.1%) formed the minor A-allele group (AA, AC) and 63
participants (82.9%) with the CC genotype formed the major
allele group (Figure 1a). This distribution accords with another
study from our group identifying the minor allele variant in 17% of
over 900 tested Israeli participants (Shenhar Tsarfaty et al., in
preparation). The ethnic differences in the prevalence of this SNP
are compatible with evolution studies of miRNAs in population
migrations45 that should be considered in functional studies of the
brain-related implications of this and other polymorphisms.
Genotype effects on limbic responses and PTSS following
emotional stimuli
The amygdala and hippocampus are rich in both GABAergic
synapses46 and AChE,32,47 suggesting that their activity may be
modulated by the cholinergic/GABAergic imbalance imposed by
the rs17228616 polymorphism in the AChE gene. Compatible with
this prediction, genotypes with the minor allele (AC, AA) were
associated with greater amygdala reactivity to emotional stimuli
compared with other volunteers (Mann–Whitney U= 269.0,
Po0.05; Figure 1b). In contrast, the rs17228616 SNP did not
inﬂuence hippocampus function (Mann–Whitney U= 308.0,
P= 0.16). Moreover, despite their neurogenetic vulnerability,8,15
PTSS levels did not differ between minor allele and major allele
individuals (Mann–Whitney U= 267.0, P= 0.09; Figure 1c). This
accords with recent genome-wide association studies, concluding
that the genetic architecture of PTSD may be determined by many
SNPs with small effects that are not directly related to the
cholinergic pathway.48,49 For the AChE gene, this outcome
plausibly reﬂects the exceedingly high G, C content that
complicates genome-wide association study data collection. It is
also possible that, in this study, the small sample size and low
variability in PTSS hindered the detection of a genotype–PTSS
association.
Genotype effects on prefrontal responses to emotional stimuli
The great majority of stressed individuals cope with their inherited
genome features and do not develop excessive PTSS or PTSD. To
explore a possible route that enables minor allele individuals to
compensate for the imbalanced amygdala signaling, we com-
pared the reactions of their vmPFC, a key component of the
cortico-limbic circuit involved in the top-down regulation of
affective subcortical circuitry, to those of their major allele peers.
The rs17228616 minor allele group members showed marginally
signiﬁcant threefold higher vmPFC activation than the major allele
group to emotional versus neutral stimuli (Mann–Whitney
U= 272.0, P= 0.058; Figure 1d). Although this ﬁnding is only
marginally signiﬁcant, we speculated that it might indicate that
greater vmPFC functioning may operate as a clinically helpful
compensatory mechanism for A-allele individuals to neutralize
their sensitivity to stress, and that they present no increase in PTSS
owing to the recruitment of the vmPFC to overcome their stress
vulnerability.
Relationship between genotype, brain response and PTSS
To test the above-mentioned theory in the search for potential
functional relevance of the neural patterns that might explain the
limited difference in PTSS between minor and major allele
individuals, we conducted an indirect effect analysis using a
bootstrapping approach.50 This method avoids the power
problem introduced by non-normality and is less restricted by
sample size. This mediation analysis revealed that volunteers with
the minor allele exhibited exacerbated amygdala reactivity to
emotional stimuli, which in turn was associated with increased
vmPFC activity (indirect effect = 0.36*, 95% conﬁdence interval:
0.04 to 0.83; Figure 2a). The observed pattern of vmPFC
hyperactivity accompanied by increased amygdala activity as
found in the minor allele group is strikingly different from
previous reports of hyperresponsive amygdala accompanied by
hyporesponsive vmPFC in PTSD,51 suggesting that minor allele
individuals may possibly achieve limited PTSS by over-recruiting
the vmPFC. To verify this conclusion, a second mediation model
was tested, which yielded a signiﬁcant indirect effect of genotype
on PTSD symptoms via vmPFC activation (indirect effect =− 0.14*,
95% conﬁdence interval: − 0.44 to − 0.007; Figure 2b), such that
the greater vmPFC response to emotional stimuli in volunteers
with the A-allele was associated with lower levels of PTSS
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compared with major allele carriers. Conversely, the indirect effect
of genotype through the amygdala was insigniﬁcant (indirect
effect =− 0.09, 95% conﬁdence interval: − 0.39 to 0.03), compatible
with the minor allele group's limited increase of trait anxiety15 and
PTSD symptoms (Figure 1b). Although mediation analyses should
be interpreted with caution and replications of these results are
required to draw ﬁrm conclusions, we conclude that the
rs17228616 polymorphism exacerbates amygdala activity, but is
not a PTSS risk factor as it promotes vmPFC hyperactivation, which
overcomes the exaggerated amygdala response.
Expression of the primate-speciﬁc miRNA-608 and its targets in
the human amygdala
Animal studies demonstrate that miRNAs expressed in the
amygdala may be involved in the stress response,52 but previous
tests of miRNA-608 and its targets in the human brain were
limited to the temporal cortex.15 To assess expression of
miRNA-608 and its target genes in the amygdala, we performed
quantitative PCR with reverse transcription measurements from
amygdala tissues of healthy human adults received from the
Netherlands Brain Bank. These analyses conﬁrmed expression,
albeit at a modest level of miRNA-608 in the amygdala of seven
donors, all homozygotes for the major allele of the rs17228616 SNP
(Figure 3a). We also observed expression of several miRNA-608
targets, including AChE in these tissues (Figure 3a). Moreover, our
measurements revealed positive correlations between several
pairs of both predicted and veriﬁed brain-expressed miRNA-608
target transcripts, following RNA quality and beta-actin normal-
ization. For the seven brains, we observed signiﬁcant positive
correlations between the GABAergic regulating CDC42, the
immune biomarker CD44, the pro-inﬂammatory cytokine IL-6
and the telomere-related TPP1 transcript (all correlations passed
false discovery rate correction of 0.05, see Table 1 and Figure 3b).
The fact that these transcripts are all expressed in the amygdala is
essential for and compatible with the proposed mechanism of
action; and the correlated expression levels indicated common
regulatory mechanism(s) for these transcripts in the human
amygdala, which could include miRNA-608-mediated control.
These ﬁndings further predicted that higher brain AChE levels,
as shown for individuals with the minor allele, would be
associated with reduced and interrelated levels of CDC42, CD44
and IL-6. This can imbalance cholinergic and GABAergic signaling,
and promote inﬂammation and consequent anxiety15 (Figure 3b).
There was no apparent effect of age or gender.
DISCUSSION
The rs17228616 SNP interferes with AChE suppression by the
cholinergic controller and primate-speciﬁc miRNA-608
(‘CholinomiR’,53), and its occurrence in healthy adults is associated
Figure 2. Models of the relationship between rs17228616 genotype,
brain activity and posttraumatic stress symptom (PTSS). (a) The
illustrated mediation model depicts a signiﬁcant indirect path of the
effect of genotype on ventromedial prefrontal cortex (vmPFC)
activity via amygdala activation. Speciﬁcally, A-allele carriers
exhibited greater amygdala reactivity to emotional stimuli, which
in turn was associated with increased vmPFC activity. (b) The
illustrated mediation model depicts a signiﬁcant indirect effect of
genotype on PTSS via vmPFC activation. Speciﬁcally, A-allele carriers
exhibited greater vmPFC response to emotional stimuli, which in
turn was associated with lower levels of PTSS symptoms. The β-
values are shown next to the arrows indicating each link in the
analysis. *Po0.05. 95% CI, 95% conﬁdence interval.
Figure 3. Interrelated expression of miR-608 and its targets in the
amygdala. (a) Human amygdala (marked red) served to extract RNA.
hsa-miR-608, as well as six of its veriﬁed and predicted targets,
including acetylcholinesterase (AChE) and CDC42 and the normal-
izing beta-actin gene are all expressed in the human amygdala
(quantitative PCR (qPCR) cycle o34 for targets, qPCR cycle o36 for
miRNA-608). Shown are Cq values as measured by qPCR. (b) Several
pairs of veriﬁed and predicted targets of hsa-miR-608 show
positively correlated expression patterns, normalized to beta-actin
and RIN (RNA integrity number) values (Po0.05, false discovery rate
corrected). Color code shows correlation matrix intensity. IL-6,
interleukin 6; miRNA, micro RNA.
Table 1. Correlations between brain-expressed miRNA-608 target
transcripts
CD44 CDC42 IL-6 TPP1
CD44 1 0.901 (0.028) 0.983 (0.002) 0.900 (0.028)
CDC42 0.901 (0.028) 1 0.861 (0.033) 0.849 (0.033)
IL-6 0.983 (0.002) 0.861 (0.033) 1 0.865 (0.033)
TPP1 0.900 (0.028) 0.849 (0.033) 0.865 (0.033) 1
Abbreviations: IL-6, interleukin 6; miRNA, micro RNA. Signiﬁcant correla-
tions between pairs of transcripts are shown along with the respective
post-false discovery rate P-values (in parentheses).
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with multiple anxiety- and inﬂammation-related changes: elevated
brain AChE activity and correspondingly reduced brain levels of
the GABAergic-related Rho GTPase CDC42, suppression of which
induces anxiety, and the inﬂammation-regulating cytokine IL-6.15
MiRNA-608 has recently been identiﬁed as a tumor-suppressive
miRNA,54,55 and has been proposed as a potential novel
therapeutic target for treating osteoarthritis.56 Yet, because
miRNA-608 is primate-speciﬁc,45 previous animal experiments of
miRNA/AChE interactions and stress34 cannot be reproduced here
to determine a causal link to stress. Despite this difﬁculty, the
current study points to the involvement of miRNA-608 in stress-
related neural reactions. We demonstrated that following chronic
stress, individuals with the rs17228616 minor allele enhance neural
activity in the amygdala accompanied by non-pathological PTSS
levels. This ﬁnding was supplemented with a marginal increase in
vmPFC response. Our model predicts multileveled effects of this
polymorphism on the neural response to emotional stimuli within
the threat circuit and its association with PTSS, as is schematically
summarized in Figure 4. We further found expression of
miRNA-608 and several of its veriﬁed and predicted target
transcripts in the amygdala, including AChE, CDC42, CD44, NACC1
and IL-6; A subset of these, involved in inﬂammation, showed very
tight positive interrelated correlations (CDC42, CD44, IL-6 and
TPP1), indicating common regulation by miR-608, among other
potential causes. Our previous work has shown such correlation in
the temporal gyrus, expanding the implications of our current
analyses beyond the amygdala. To the best of our knowledge, our
current study is the ﬁrst to implicate a SNP in a noncoding region
in measurable brain fMRI changes under emotional stimuli, and
the ﬁrst to suggest a functional coping mechanism with a risk-
associated SNP.
Although PTSS were not directly related to the polymorphism,
our fMRI results provide support for the relation between the
rs17228616 polymorphism and PTSS by demonstrating that
individuals with the rs17228616 minor allele show heightened
amygdala response to emotional stimuli. This is compatible with
earlier functional neuroimaging studies reporting exaggerated
amygdala activation in patients with PTSD compared with control
subjects27,28 and support the notion that amygdala hyperactiva-
tion is a predisposing factor for developing stress-related
disorders.8,29 The ﬁnding that minor allele individuals show
Figure 4. Schematic presentation of how the rs17228616 single-nucleotide polymorphism (SNP) in the acetylcholinesterase (AChE) gene may
affect the vulnerability to stress. This SNP interrupts miRNA-608/AChE interaction, leading to (1) elevated brain AChE activity and thus reduced
cholinergic signaling, (2) reduction in the GABAergic modulator CDC42, limiting the inhibitory GABAergic signaling and (3) reduced IL-6 levels,
effecting inﬂammatory pathways. Together, these signaling pathway impairments may enhance amygdala reactivity to emotional stimuli of
minor allele individuals due to insufﬁcient suppression of stress-related increases in cholinergic signaling and reduced inhibitory GABAergic
signaling. As a coping mechanism under trauma load, these individuals over-recruit the ventromedial prefrontal cortex to downregulate the
amygdala, and thus develop limited posttraumatic stress syndrome. Broken arrows represent reduced inhibitory input. The effects of this SNP,
of stress exposure and of SNP-exposure interactions are represented by black, purple and striped black/purple arrows, respectively. IL-6,
interleukin 6; miRNA, micro RNA.
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hyperactive amygdala but do not present elevated PTSS has led us
to jointly investigate how they cope with stressful challenges.
The rs17228616 minor allele group showed a trend of increased
vmPFC activation compared with the major allele group. This
ﬁnding was further strengthened by a signiﬁcant indirect path
analysis showing that soldiers with the minor A-allele also
exhibited higher levels of amygdala activity compared with those
with the major C-allele, and that the minor allele was involved in
increased recruitment of the vmPFC in these volunteers. The
results of this mediation analysis suggest that minor allele
individuals may recruit the vmPFC to downregulate their elevated
amygdala reactivity more effectively than the major allele group.
An additional mediation analysis suggested that the elevated
vmPFC activity has a clinically protective role in A-allele
volunteers, such that they attained lower than predicted levels
of PTSS compared to major allele carriers by increasing the
recruitment of their vmPFC. However, other, yet-unknown
explanations for these fMRI results may exist. To validate or
exclude this hypothesis, future studies could test whether parallel
vmPFC hyperactivation occurs in other cases where the inherited
tendency to develop PTSS is compensated for, and whether PTSD
patients with the A-allele lack this compensatory mechanism and
thus develop and maintain high levels of symptoms.
Amygdala enhancement in minor allele individuals may be
driven by either the imbalanced cholinergic, GABAergic and/or
inﬂammation signaling, which are all intensiﬁed under stressful
environments57 (Figure 4). Apart from their direct effects on the
amygdala, GABA and acetylcholine could possibly inﬂuence this
phenotype indirectly through other regions within the threat
circuit, such as the hippocampus.24,58,59 However, the rs17228616
SNP was not associated with modiﬁed hippocampus activity,
suggesting that individual differences in the AChE system likely
explain only part of the neural changes associated with PTSS. This
ﬁnding also excludes hippocampal involvement in the limited
PTSS of minor allele individuals. An alternative explanation is that
although their reduced cholinergic signaling causes decreased
hippocampal activity, the hippocampus is upregulated back to
normal levels by the overrecruitment of the vmPFC.35 To elucidate
this, focused studies of the effects of this gene on hippocampus–
vmPFC connectivity are needed.
The noncoding SNPs affecting higher brain functions and
chronic disease include a polymorphism in the 3′-untranslated
region of the brain-expressed human Slit and Trk-like 1 (SLITRK1)
gene, which strengthens an existing miR-189 target site, supports
neurite growth and is involved in Tourette’s syndrome and
attention-deﬁcit hyperactivity disorder.60 Also, college students
homozygous for the ancestral A variant of an A4G polymorphism,
which changes miRNA-96 regulation of the aggressive behavior-
associated HTR1B gene, exhibit more conduct-disorder behaviors
than individuals with the G allele.61 Our ﬁndings, in comparison
implicate the ability to cope with miRNA dysregulation in brain-
related diseases. The genetic variations evident in the miRNA-608
gene itself (the 'seed' region) may alter its binding and thus
activity.62 Consequently, in addition to the 3′-untranslated region
polymorphism, miRNA polymorphisms can potentially serve as
additional biomarkers for PTSS, which warrants investigation.
There are several limitations to this study. The neurocircuitry
models posit that in PTSD, the vmPFC fails to inhibit the amygdala,
which leads to exaggerated threat responses and emotion
regulation deﬁcits.37 The currently observed effect thus reﬂects
differential increases in the reactivity of the amygdala following
prolonged exposure to stress and trauma.63 However, the
genotype effect may also reﬂect pre-trauma vulnerability factors
rather than consequences of stressful situations.8,29 The prospec-
tive studies examining the relation between the rs17228616
polymorphism and amygdala activity before and after stress
insults of variable impact and length are required to disentangle
this question. In addition, the currently studied population
consisted of healthy Israel Defense Forces soldiers selected by
extensive mental and physical screenings, and the rs17228616
polymorphism may have a different effect in the general
population; genuine highly anxious populations should be tested
before the results can be generalized.64 However, the use of a
relatively healthy sample minimizes confounding factors such as
comorbidities and medication use, thus representing a good
approach for studying PTSS as a continuum. Nevertheless, the use
of a small homogenous sample may have reduced PTSS variability,
weakening the statistical power to detect all statistical effects, thus
warranting additional studies on larger and more variable trauma-
prone populations, such as paramedics or ﬁreﬁghters. Further, the
sample size of amygdala tissues and soldiers participating in the
fMRI experiment may be too small to detect all the associations. It
is also possible that the results of this study may be only
applicable to chronic cases and not to acute stress symptoms.
To conclude, using a unique population at high risk for chronic
stress exposure, we found that the rs17228616 gene variant
inﬂuences neural responses to emotional stimuli; but that in the
context of trauma load, its effect on PTSS is limited, plausibly due
to intensiﬁed recruitment of the vmPFC. Importantly, our ﬁndings
support the concept that noncoding RNAs may be involved in
PTSS, and should be integrated into a neural model of the
disorder. This study highlights the effectiveness of combined
genomic and neuroimaging methods in the identiﬁcation of
intermediate phenotypes for PTSS and other psychiatric disorders
and provides a further step towards personalized medicine in
psychiatry by identifying previously neglected genetic variants of
disease risks that may contribute to its vulnerability. Notably, our
current ﬁndings point to one possible PTSS risk pathway, in which
a risk genotype predisposes individuals to increased fear reactivity.
This involves exaggerated amygdala responses that are suppo-
sedly downregulated by the vmPFC to avoid the development of
PTSS. These ﬁndings also point to potential new treatment
avenues by neuromodulation techniques targeting the amygdala
or amygdala–vmPFC interactions.
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